Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 9/20 | 0.72 |
| ▸ | MAPT | P10636 | 9/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.72 |
| ▸ | NPC1 | O15118 | 5/20 | 0.72 |
| ▸ | RAB9A | P51151 | 5/20 | 0.72 |
| ▸ | GLA | P06280 | 4/20 | 0.72 |
| ▸ | GAA | P10253 | 4/20 | 0.72 |
| ▸ | SNCA | P37840 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | RORC | P51449 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12422217 | 0.90 | MAPT (0.81) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL31120302 | 0.86 | APP (0.81) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL1986928 | 0.84 | MAPT (0.68) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL2244143 | 0.84 | APP (0.72) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL13453290 | 0.84 | APP (1.00) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL5349180 | 0.84 | MAPT (0.72) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL12355589 | 0.84 | MAPT (0.72) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL492713 | 0.84 | APP (1.00) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL507097 | 0.83 | MAPT (0.71) | APPMAPTKDM4ENPC1RAB9A | |
| SCHEMBL17404434 | 0.83 | APP (0.65) | APPMAPTKDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106432132-A | Preparation method of 2-arylbenzothiazole compound | 西北师范大学 | 2017-02-22 | — | — | CN | disclosed |
| US-7754348-B2 | charge transfer compounds; glass transition temperature; heat resistance; low driving voltage | LUMINESCENE TECHNOLOGY CORP. (TW) | 2010-07-13 | — | — | US | disclosed |
| US-20080265746-A1 | PHENANTHROLINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | Yen, Feng Wen (TW) | 2008-10-30 | — | — | US | disclosed |
| EP-0020305-B1 | 1-HYDROXY-4-HETEROARYLAMINO ANTHRAQUINONE DYESTUFFS, THEIR PREPARATION AND THEIR USE IN DYEING POLYESTERS IN THE MASS | CIBA-GEIGY AG (CH) | 1982-08-04 | — | — | EP | disclosed |
| US-4341896-A | DYESTUFF FOR POLYESTER | CIBA-GEIGY CORPORATION (US) | 1982-07-27 | — | — | US | disclosed |
| EP-0020305-A1 | 1-Hydroxy-4-heteroarylamino anthraquinone dyestuffs, their preparation and their use in dyeing polyesters in the mass | CIBA-GEIGY AG (CH) | 1980-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080265746-A1 | PHENANTHROLINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | AHR, HAX1, ARNT | APP 1236/4885MAPT 3772/4885KDM4E 2523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.